{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:22:35Z","timestamp":1781508155511,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12967-015-0629-3","type":"journal-article","created":{"date-parts":[[2015,8,26]],"date-time":"2015-08-26T10:09:40Z","timestamp":1440583780000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Effect of Berberine on promoting the excretion of cholesterol in high-fat diet-induced hyperlipidemic hamsters"],"prefix":"10.1186","volume":"13","author":[{"given":"Xiao-Yang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Xiong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Yu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Heng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Ying","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Wen","family":"Shou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangchao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Dong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,27]]},"reference":[{"key":"629_CR1","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm1135","volume":"10","author":"WJ Kong","year":"2004","unstructured":"Kong WJ, Wei J, Abidi P, Lin MH, Inaba S, Li C et al (2004) Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 10:1344\u20131351","journal-title":"Nat Med"},{"key":"629_CR2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1476-4598-10-39","volume":"10","author":"S Mahata","year":"2011","unstructured":"Mahata S, Bharti AC, Shukla S, Tyagi A, Husain SA, Das BC (2011) Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells. Mol Cancer 10:39","journal-title":"Mol Cancer"},{"key":"629_CR3","doi-asserted-by":"crossref","first-page":"9218","DOI":"10.3390\/molecules16119218","volume":"16","author":"L Gao","year":"2011","unstructured":"Gao L, He D, Liu JH, Yan W, Gao S, Wang L (2011) Berberine and itraconazole are not synergistic in vitro against Aspergillus fumigatus isolated from clinical patients. Molecules 16:9218\u20139233","journal-title":"Molecules"},{"key":"629_CR4","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/j.bmcl.2011.01.101","volume":"21","author":"M Bahar","year":"2011","unstructured":"Bahar M, Deng Y, Zhu XH, He SS, Pandharkar T, Drew ME et al (2011) Potent antiprotozoal activity of a novel semi-synthetic berberine derivative. Bioorg Med Chem Lett 21:2606\u20132610","journal-title":"Bioorg Med Chem Lett"},{"key":"629_CR5","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejphar.2007.12.011","volume":"582","author":"L Jin","year":"2008","unstructured":"Jin L, Xue HY, Jin LJ, Li SY, Xu YP (2008) Antioxidant and pancreas-protective effect of aucubin on rats with streptozotocin-induced diabetes. Eur J Pharmacol 582:162\u2013167","journal-title":"Eur J Pharmacol"},{"key":"629_CR6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ejphar.2008.12.056","volume":"606","author":"JY Zhou","year":"2009","unstructured":"Zhou JY, Zhou SW, Tang JL, Zhang KB, Guang LX, Huang YP et al (2009) Protective effect of berberine on beta cells in streptozotocin- and high-carbohydrate\/high-fat diet-induced diabetic rats. Eur J Pharmacol 606:262\u2013268","journal-title":"Eur J Pharmacol"},{"key":"629_CR7","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1248\/bpb.28.1431","volume":"28","author":"BS Ko","year":"2005","unstructured":"Ko BS, Choi SB, Park SK, Jang JS, Kim YE, Park S (2005) Insulin sensitizing and insulinotropic action of berberine from Cortidis rhizoma. Biol Pharm Bull 28:1431\u20131437","journal-title":"Biol Pharm Bull"},{"key":"629_CR8","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1517\/14712598.2012.704014","volume":"12","author":"G Derosa","year":"2012","unstructured":"Derosa G, Maffioli P, Cicero AF (2012) Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials. Expert Opin Biol Ther 12:1113\u20131124","journal-title":"Expert Opin Biol Ther"},{"key":"629_CR9","doi-asserted-by":"crossref","first-page":"7707","DOI":"10.1523\/JNEUROSCI.2211-04.2004","volume":"24","author":"TD Stein","year":"2004","unstructured":"Stein TD, Anders NJ, DeCarli C, Chan SL, Mattson MP, Johnson JA (2004) Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSW mice resulting in tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis. J Neurosci 24:7707\u20137717","journal-title":"J Neurosci"},{"key":"629_CR10","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/00005344-199405000-00005","volume":"23","author":"YX Wang","year":"1994","unstructured":"Wang YX, Yao XJ, Tan YH (1994) Effects of berberine on delayed after depolarizations in ventricular muscles in vitro and in vivo. J Cardiovasc Pharmacol 23:716\u2013722","journal-title":"J Cardiovasc Pharmacol"},{"key":"629_CR11","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ejphar.2011.03.024","volume":"660","author":"SF Dong","year":"2011","unstructured":"Dong SF, Hong Y, Liu M, Hao YZ, Yu HS, Liu Y et al (2011) Berberine attenuates cardiac dysfunction in hyperglycemic and hypercholesterolemic rats. Eur J Pharmacol 660:368\u2013374","journal-title":"Eur J Pharmacol"},{"key":"629_CR12","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/S0024-3205(03)00144-9","volume":"72","author":"Y Hong","year":"2003","unstructured":"Hong Y, Hui SS, Chan BT, Hou J (2003) Effect of berberine on catecholamine levels in rats with experimental cardiac hypertrophy. Life Sci 72:2499\u20132507","journal-title":"Life Sci"},{"key":"629_CR13","first-page":"49","volume":"13","author":"J Wei","year":"2005","unstructured":"Wei J, Jiang JD, Wu JD, Wang SK, Wang ZZ, Pan HN et al (2005) Research on the effective improvement of hyperlipidemia by berberine. Chin J Diabetes 13:49\u201351","journal-title":"Chin J Diabetes"},{"key":"629_CR14","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.metabol.2008.01.037","volume":"57","author":"WJ Kong","year":"2008","unstructured":"Kong WJ, Wei J, Zuo ZY, Ym Wang, Song DQ, You XF et al (2008) Combination of simvastatin with berberine improves the lipid-lowering efficacy. Metabolism 57:1029\u20131037","journal-title":"Metabolism"},{"key":"629_CR15","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1021\/jm801157z","volume":"52","author":"YH Li","year":"2009","unstructured":"Li YH, Yang P, Kong WJ, Wang YX, Hu CQ, Zuo ZY et al (2009) Berberine analogues as a novel class of the low-density-lipoprotein receptor up-regulators: synthesis, structure\u2013activity relationships, and cholesterol-lowering efficacy. J Med Chem 52:492\u2013501","journal-title":"J Med Chem"},{"key":"629_CR16","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1194\/jlr.M600020-JLR200","volume":"47","author":"JM Brusq","year":"2006","unstructured":"Brusq JM, Ancellin N, Grondin P, Guillard R, Martin S, Saintillan Y et al (2006) Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine. J Lipid Res 47:1281\u20131288","journal-title":"J Lipid Res"},{"key":"629_CR17","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1172\/JCI35541","volume":"119","author":"R Singh","year":"2009","unstructured":"Singh R, Xiang YQ, Wang YJ, Baikati K, Cuervo AM, Luu YK et al (2009) Autophagy regulates adipose mass and differentiation in mice. J Clin Investig 119:3329\u20133339","journal-title":"J Clin Investig"},{"key":"629_CR18","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbrc.2006.07.095","volume":"348","author":"C Huang","year":"2006","unstructured":"Huang C, Zhang Y, Gong Z, Sheng X, Li Z, Zhang W et al (2006) Berberine inhibits 3T3-L1 adipocyte differentiation through the PPAR\u03b3 pathway. Biochem Biophys Res Commun 348:571\u2013578","journal-title":"Biochem Biophys Res Commun"},{"key":"629_CR19","first-page":"389","volume":"24","author":"MK He","year":"2004","unstructured":"He MK, Lu FE, Wang KF, Leng SH, Xu LJ, Zhou X (2004) Effect and mechanisms of berberine on hyperlipidemic and insulin resistant rats. China J Hosp Pharm 24:389\u2013391","journal-title":"China J Hosp Pharm"},{"key":"629_CR20","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.metabol.2014.05.013","volume":"63","author":"Y Wang","year":"2014","unstructured":"Wang Y, Yi X, Ghanam K, Zhang S, Zhao T, Zhu X (2014) Berberine decreases cholesterol levels in rats through multiple mechanisms, including inhibition of cholesterol absorption. Metabolism 63:1167\u20131177","journal-title":"Metabolism"},{"key":"629_CR21","first-page":"19","volume":"31","author":"CL Li","year":"2014","unstructured":"Li CL, Wang YQ (2014) Research advance on treating hyperlipidemia of berberine. Chin J Drug Eval 31:19\u201322","journal-title":"Chin J Drug Eval"},{"key":"629_CR22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0002-9149(03)00533-2","volume":"92","author":"XH Zeng","year":"2003","unstructured":"Zeng XH, Zeng XJ, Li YY (2003) Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 92:173\u2013176","journal-title":"Am J Cardiol"},{"key":"629_CR23","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.atherosclerosis.2014.06.001","volume":"235","author":"S Lim","year":"2014","unstructured":"Lim S, Oh PC, Sakuma I, Koh KK (2014) How to balance cardiorenometabolic benefits and risks of statins. Atherosclerosis 235:644\u2013648","journal-title":"Atherosclerosis"},{"key":"629_CR24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1472-6750-13-68","volume":"13","author":"A Maciejak","year":"2013","unstructured":"Maciejak A, Leszczynska A, Warchol I, Gora M, Kaminska J, Plochocka D et al (2013) The effects of statins on the mevalonic acid pathway in recombinant yeast strains expressing human HMG-CoA reductase. BMC Biotechnol 13:68","journal-title":"BMC Biotechnol"},{"key":"629_CR25","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.2174\/13894501113149990193","volume":"14","author":"S Abdul-Majeed","year":"2013","unstructured":"Abdul-Majeed S, Mohamed N, Soelaiman IN (2013) A review on the use of statins and tocotrienols, individually or in combination for the treatment of osteoporosis. Curr Drug Targets 14:1579\u20131590","journal-title":"Curr Drug Targets"},{"key":"629_CR26","doi-asserted-by":"crossref","first-page":"e66786","DOI":"10.1371\/journal.pone.0066786","volume":"8","author":"CY Jiang","year":"2013","unstructured":"Jiang CY, Yang KM, Yang L, Miao ZX, Wang YH, Zhu HB (2013) A 1H NMR-based metabonomic investigation of time-related metabolic trajectories of the plasma, urine and liver extracts of hyperlipidemic hamsters. PLoS One 8:e66786","journal-title":"PLoS One"},{"key":"629_CR27","first-page":"313808","volume":"2015","author":"C Liu","year":"2015","unstructured":"Liu C, Wang Z, Song Y, Wu D, Zheng X, Li P et al (2015) Effects of berberine on amelioration of hyperglycemia and oxidative stress in high glucose and high fat diet-induced diabetic hamsters in vivo. BioMed Res Int 2015:313808","journal-title":"BioMed Res Int"},{"key":"629_CR28","doi-asserted-by":"crossref","first-page":"e77969","DOI":"10.1371\/journal.pone.0077969","volume":"8","author":"XS Tan","year":"2013","unstructured":"Tan XS, Ma JY, Feng R, Ma C, Chen WJ, Sun YP et al (2013) Tissue distribution of berberine and its metabolites after oral administration in rats. PLoS One 8:e77969","journal-title":"PLoS One"},{"key":"629_CR29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0168-6496(03)00285-X","volume":"47","author":"P G\u00e9rard","year":"2004","unstructured":"G\u00e9rard P, B\u00e9guet F, Lepercq P, Rigottier-Gois L, Rochet V, Andrieux C et al (2004) Gnotobiotic rats harboring human intestinal microbiota as a model for studying cholesterol-to-coprostanol conversion. FEMS Microbiol Ecol 47:337\u2013343","journal-title":"FEMS Microbiol Ecol"},{"key":"629_CR30","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/jn\/71.4.405","volume":"71","author":"WW Wells","year":"1960","unstructured":"Wells WW, Anderson SC, Ma RQ (1960) Lactose diets and cholesterol metabolism. I. Cholesterol absorption, coprostanol formation and bile acid excretion in the rat. J Nutr 71:405\u2013410","journal-title":"J Nutr"},{"key":"629_CR31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0039-128X(95)00173-N","volume":"61","author":"D Ren","year":"1996","unstructured":"Ren D, Li L, Schwabacher AW, Young JW, Beitz DC (1996) Mechanism of cholesterol reduction to coprostanol by Eubacterium coprostanoligenes ATCC 51222. Steroids 61:33\u201340","journal-title":"Steroids"},{"key":"629_CR32","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0021-9258(18)71221-0","volume":"211","author":"RS Rosenfeld","year":"1954","unstructured":"Rosenfeld RS, Fukushima DK, Hellman L, Gallagher TF (1954) The transformation of cholesterol to coprostanol. J Biol Chem 211:301\u2013311","journal-title":"J Biol Chem"},{"key":"629_CR33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1039\/C3FO60445D","volume":"5","author":"YL Hsieh","year":"2014","unstructured":"Hsieh YL, Yeh YH, Lee YT, Hsieh CH (2014) Ameliorative effect of pracparatum mungo extract on high cholesterol diets in hamsters. Food Funct 5:149\u2013157","journal-title":"Food Funct"},{"key":"629_CR34","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.atherosclerosis.2008.02.004","volume":"201","author":"J Cameron","year":"2008","unstructured":"Cameron J, Ranheim T, Kulseth MA, Leren TP, Berge KE (2008) Berberine decreases PCSK9 expression in HepG2 cells. Atherosclerosis 201:266\u2013273","journal-title":"Atherosclerosis"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-015-0629-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T23:05:24Z","timestamp":1653087924000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.translational-medicine.com\/content\/13\/1\/278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,27]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["629"],"URL":"https:\/\/doi.org\/10.1186\/s12967-015-0629-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,27]]},"article-number":"278"}}